Stock Price Quote

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5098.95-24.95 (-0.49 %)
PREV CLOSE ( ) 5123.90
OPEN PRICE ( ) 5115.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 211
TODAY'S LOW / HIGH ( )5071.70 5159.30
52 WK LOW / HIGH ( )4640.3 5640
NSE5118.75-9.65 (-0.19 %)
PREV CLOSE( ) 5128.40
OPEN PRICE ( ) 5147.15
BID PRICE (QTY) 5118.75 (27)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5556
TODAY'S LOW / HIGH( ) 5000.00 5165.40
52 WK LOW / HIGH ( )4636.55 5642.85
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-04 1967
Management Info
Suresh Talwar - Chairman Milind Thatte - Managing Director
Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (E),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

27Mar Procter & Gamble Hygiene and Health Ca
Procter & Gamble Hygiene and Health Care has informed that the Compa..
04Mar Procter & Gamble Health informs about
Procter & Gamble Health has informed that it has received informatio..
06Feb Procter & Gamble Health informs about
Procter & Gamble Health has informed that the Board has approved int..
20Jan Procter & Gamble Health informs about
Procter & Gamble Health has informed that it has been informed by it..
21Dec Procter & Gamble Health informs about
Procter & Gamble Health has informed that it received intimation fro..

Financials

in Millions
QTR Mar 24 ANNUAL 23
Net Profit465.62294.7
Gross Profit 627.2 3142
Operating Profit 697.13430.7
Net Sales 2524.812296.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2603.15 (8.84%)
M.Cap ( in Cr)1608.23
Dr. Reddy's Lab (BSE)
peergroup  6721.65 (1.91%)
M.Cap ( in Cr)112137.09
Hester Biosciences (BSE)
peergroup  2692.95 (1.97%)
M.Cap ( in Cr)2290.86
Fredun Pharma (BSE)
peergroup  863.10 (4.91%)
M.Cap ( in Cr)407.53
Mankind Pharma (BSE)
peergroup  2151.70 (1.52%)
M.Cap ( in Cr)86204.66

Shareholding Pattern

MUTUAL FUNDS/UTI 9.86%
PROMOTERS 51.82%
FI/BANKS/INSURANCE 3.55%
NON-INSTITUTION 28.21%
GOVERNMENT 0%
FII 0%

About Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd. was incorporated in the year 1967. Its today's share price is 5098.95. Its current market capitalisation stands at Rs 8463.94 Cr. In the latest quarter, company has reported Gross Sales of Rs. 13282.4 Cr and Total Income of Rs.12480.1 Cr. The company's management includes Zeal Rupani, S Madhavan, Rani Ajit Jadhav, Seema Sambasivan, Aalok Agrawal, Milind Thatte, Lokesh Chandak, Suresh Talwar.

It is listed on the BSE with a BSE Code of 500126 , NSE with an NSE Symbol of PGHL and ISIN of INE199A01012. It's Registered office is at Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (E)Mumbai-400099, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, Haribhakti & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.